Stock listing

Haemonetics Corporation

Selected listing: HAZ · MUN · EUR · DE

Haemonetics Corporation (Munich:HAZ), Health Technology. Latest release Sep 30, 2026: Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027…

HAZ:MUNEURDEUpdated October 2, 2026

Ticker: Munich:HAZ
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Munich
Currency: EUR

About Haemonetics Corporation

The company specializes in blood management solutions, providing products and services that enhance the safety and efficiency of blood collection and transfusion processes. Haemonetics is committed to innovation and improving patient outcomes in healthcare settings.

Latest news from Haemonetics Corporation

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026

September 30, 2026

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

August 6, 2026

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

August 3, 2026

Martin Madaus Elected to Haemonetics Board of Directors

July 28, 2026

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026

July 8, 2026

All Haemonetics Corporation news →

Events

Replays

Haemonetics Corporation (HAE) Q1 2027 Earnings Call
Thu, Aug 06, 2026 · 08:00 AM ET
Watch
Haemonetics Corporation (HAE) Q4 2026 Earnings Call
Thu, May 07, 2026 · 08:00 AM ET
Watch
Haemonetics Corporation (HAE) Q3 2026 Earnings Call
Thu, Feb 05, 2026 · 08:00 AM ET
Watch

Research Haemonetics Corporation

Haemonetics Corporation company profile

View the public company page for Haemonetics Corporation on 6ix.

Haemonetics Corporation news

Read company news and market updates connected to Haemonetics Corporation.

Haemonetics Corporation investor events

Find investor webinars, events, and replay context for Haemonetics Corporation.